Total Payments
$1.2M
2024 Payments
$212,204
Companies
37
Transactions
1,627
Medicare Patients
3,640
Medicare Billing
$245,655
Payment Breakdown by Category
Other$994,061 (81.0%)
Travel$133,954 (10.9%)
Consulting$68,840 (5.6%)
Food & Beverage$29,930 (2.4%)
Education$640.03 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $904,361 | 301 | 73.7% |
| Travel and Lodging | $133,954 | 410 | 10.9% |
| Honoraria | $85,400 | 29 | 7.0% |
| Consulting Fee | $68,840 | 28 | 5.6% |
| Food and Beverage | $29,930 | 820 | 2.4% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $4,300 | 1 | 0.4% |
| Education | $640.03 | 38 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $283,052 | 234 | $0 (2019) |
| Amgen Inc. | $216,516 | 249 | $0 (2024) |
| UCB, Inc. | $128,407 | 149 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $123,455 | 172 | $0 (2024) |
| GENZYME CORPORATION | $113,385 | 103 | $0 (2024) |
| ABBVIE INC. | $89,486 | 176 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $84,105 | 88 | $0 (2022) |
| PFIZER INC. | $42,540 | 91 | $0 (2022) |
| Valeant Pharmaceuticals North America LLC | $39,663 | 8 | $0 (2017) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $25,441 | 16 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $212,204 | 249 | UCB, Inc. ($90,491) |
| 2023 | $70,742 | 100 | Amgen Inc. ($46,482) |
| 2022 | $118,991 | 172 | Amgen Inc. ($63,662) |
| 2021 | $110,985 | 189 | Amgen Inc. ($44,754) |
| 2020 | $92,118 | 129 | Sun Pharmaceutical Industries Inc. ($34,708) |
| 2019 | $175,684 | 237 | Celgene Corporation ($70,115) |
| 2018 | $241,757 | 299 | Celgene Corporation ($99,885) |
| 2017 | $204,945 | 252 | Celgene Corporation ($113,052) |
All Payment Transactions
1,627 individual payment records from CMS Open Payments — Page 1 of 66
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,725.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.04 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | Amgen Inc. | Otezla (Drug) | Travel and Lodging | Cash or cash equivalent | $94.74 | General |
| Category: Inflammation | ||||||
| 11/22/2024 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: Inflammation | ||||||
| 11/22/2024 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $110.00 | General |
| Category: Inflammation | ||||||
| 11/18/2024 | UCB, Inc. | Bimzelx (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,500.00 | General |
| Category: Immunology | ||||||
| 11/18/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | Cash or cash equivalent | $86.03 | General |
| Category: Immunology | ||||||
| 11/18/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | Cash or cash equivalent | $35.99 | General |
| Category: Immunology | ||||||
| 11/18/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | Cash or cash equivalent | $22.36 | General |
| Category: Immunology | ||||||
| 11/18/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | Cash or cash equivalent | $21.00 | General |
| Category: Immunology | ||||||
| 11/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | UCB, Inc. | Bimzelx (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,380.00 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Dermatology | ||||||
| 11/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | In-kind items and services | $617.95 | General |
| Category: Immunology | ||||||
| 11/07/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | In-kind items and services | $542.34 | General |
| Category: Immunology | ||||||
| 11/07/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | In-kind items and services | $251.90 | General |
| Category: Immunology | ||||||
| 11/07/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $94.21 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Inflammation | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $8.17 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $86.97 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/24/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | Cash or cash equivalent | $86.03 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 477 | 828 | $83,801 | $29,594 |
| 2022 | 7 | 624 | 1,049 | $141,941 | $45,962 |
| 2021 | 13 | 1,108 | 1,754 | $238,984 | $85,760 |
| 2020 | 15 | 1,431 | 2,373 | $258,074 | $84,339 |
Total Patients
3,640
Total Services
6,004
Medicare Billing
$245,655
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 109 | 142 | $24,850 | $8,731 | 35.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 90 | 138 | $17,802 | $5,775 | 32.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 91 | 118 | $12,862 | $4,701 | 36.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 35 | 41 | $6,478 | $3,071 | 47.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 25 | $6,200 | $2,167 | 35.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $5,037 | $1,548 | 30.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 69 | 303 | $4,042 | $1,440 | 35.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 21 | 22 | $4,290 | $1,352 | 31.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 16 | 16 | $2,240 | $807.45 | 36.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 229 | 321 | $58,422 | $19,269 | 33.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 109 | 131 | $33,536 | $10,690 | 31.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 116 | 170 | $22,950 | $7,155 | 31.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 47 | 52 | $11,700 | $4,060 | 34.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $5,408 | $1,651 | 30.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 84 | 336 | $4,704 | $1,639 | 34.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 23 | 23 | $5,221 | $1,497 | 28.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 344 | 481 | $81,289 | $29,125 | 35.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 206 | 261 | $62,640 | $22,780 | 36.4% |
| 17000 | Destruction of skin growth | Office | 2021 | 179 | 276 | $33,948 | $11,559 | 34.0% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 61 | 70 | $14,700 | $5,469 | 37.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 57 | 57 | $11,856 | $4,230 | 35.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 32 | 32 | $10,016 | $3,563 | 35.6% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 115 | 442 | $5,304 | $2,014 | 38.0% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 27 | 27 | $5,211 | $1,975 | 37.9% |
| 17280 | Destruction of malignant growth (0.5 centimeters or less) of face, ears, eyelids, nose, lips, or mouth | Office | 2021 | 16 | 19 | $4,921 | $1,778 | 36.1% |
About Dr. Eric Baum, M.D
Dr. Eric Baum, M.D is a Specialist healthcare provider based in Gadsden, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285669077.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Baum, M.D has received a total of $1.2M in payments from pharmaceutical and medical device companies, with $212,204 received in 2024. These payments were reported across 1,627 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($904,361).
As a Medicare-enrolled provider, Baum has provided services to 3,640 Medicare beneficiaries, totaling 6,004 services with total Medicare billing of $245,655. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Gadsden, AL
- Active Since 07/11/2006
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1285669077
Products in Payments
- Otezla (Drug) $486,480
- DUPIXENT (Biological) $149,977
- Bimzelx (Biological) $92,491
- SKYRIZI (Biological) $52,228
- DUPIXENT DUPILUMAB INJECTION (Biological) $51,385
- EUCRISA (Drug) $41,430
- ILUMYA (Biological) $36,654
- Cimzia (Drug) $31,493
- DUPIXENT (Drug) $28,370
- HALOG (Drug) $24,788
- Skyrizi (Biological) $21,054
- COSENTYX (Biological) $15,442
- Winlevi (Drug) $12,294
- TOPICORT (desoximetasone) Topical Spray, 0.25% (Drug) $11,887
- SILIQ (Drug) $10,075
- HUMIRA (Biological) $8,725
- Sitavig (Drug) $7,626
- Seysara (Drug) $6,016
- Humira (Biological) $5,101
- ALTRENO (Drug) $5,082
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Gadsden
Anthony Catanzaro, M.d, M.D
Specialist — Payments: $6,456
Specialist $6,456
Charles Dabbs, M.d, M.D
Specialist — Payments: $5,278
Specialist $5,278
Henry Ruiz, M.d, M.D
Specialist — Payments: $4,951
Specialist $4,951
Dr. Terisa Thomas, M.d, M.D
Specialist — Payments: $1,837
Specialist $1,837
Bryan Grissett, M.d, M.D
Specialist — Payments: $1,588
Specialist $1,588
George Robinson, M.d, M.D
Specialist — Payments: $490.63
Specialist $490.63